Skip to main content

Table 1 Drug therapies administered in patients with hypertension and/or diabetes

From: Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients

  Total DIA without HYP DIA with HYP HYP without DIA
Antihypertensive drugs (%) 47.21   100.00 58.19
Diuretics (%) 41.67   50.00 43.26
ACEi (%) 39.58   43.75 33.65
ARB (%) 34.03   40.00 35.58
β-blockers (%) 29.86   31.25 32.69
α-blockers (%) 5.56   7.50 2.88
Calcium antagonists (%) 18.06   23.75 18.27
Other antihypertensive drugs (%) 1.39   0.00 1.92
Antidiabetic drugs (%) 21.987 84.38 87.50  
Insulin (%) 20.90 29.63 20.00  
Metformin (%) 83.58 85.19 80.00  
Sulfonylureas (%) 32.84 14.81 37.14  
Meglitinides (%) 2.99 7.41 4.29  
α-glucosidase inhibitors (%) 1.49   1.43  
Glitazones (%)    7.14  
  1. Data are expressed as percentages. ACEi, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers; DIA, patients with diabetes; HYP, patients with hypertension.